位置:首页 > 蛋白库 > BLH_UNCMB
BLH_UNCMB
ID   BLH_UNCMB               Reviewed;         275 AA.
AC   Q4PNI0;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 1.
DT   03-AUG-2022, entry version 36.
DE   RecName: Full=Beta-carotene 15,15'-dioxygenase {ECO:0000305};
DE            EC=1.13.11.63 {ECO:0000255|HAMAP-Rule:MF_02093, ECO:0000269|PubMed:19366683};
GN   Name=blh;
OS   Uncultured marine bacterium 66A03.
OC   Bacteria; environmental samples.
OX   NCBI_TaxID=331677;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=16008504; DOI=10.1371/journal.pbio.0030273;
RA   Sabehi G., Loy A., Jung K.H., Partha R., Spudich J.L., Isaacson T.,
RA   Hirschberg J., Wagner M., Beja O.;
RT   "New insights into metabolic properties of marine bacteria encoding
RT   proteorhodopsins.";
RL   PLoS Biol. 3:E273-E273(2005).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, METAL-BINDING SITES, REACTION
RP   MECHANISM, AND MUTAGENESIS OF HIS-21; HIS-78; HIS-188 AND HIS-192.
RX   PubMed=19366683; DOI=10.1074/jbc.m109.002618;
RA   Kim Y.S., Kim N.H., Yeom S.J., Kim S.W., Oh D.K.;
RT   "In vitro characterization of a recombinant Blh protein from an uncultured
RT   marine bacterium as a beta-carotene 15,15'-dioxygenase.";
RL   J. Biol. Chem. 284:15781-15793(2009).
RN   [3]
RP   BIOTECHNOLOGY.
RX   PubMed=20229064; DOI=10.1007/s10529-010-0239-3;
RA   Kim Y.S., Park C.S., Oh D.K.;
RT   "Retinal production from beta-carotene by beta-carotene 15,15'-dioxygenase
RT   from an unculturable marine bacterium.";
RL   Biotechnol. Lett. 32:957-961(2010).
CC   -!- FUNCTION: Catalyzes the cleavage of beta-carotene at its central double
CC       bond (15,15') to yield two molecules of all-trans-retinal. Exhibits the
CC       highest activity for beta-carotene, followed by beta-cryptoxanthin,
CC       beta-apo-4'-carotenal, alpha-carotene, and gamma-carotene in decreasing
CC       order, but has no activity on beta-apo-8'-carotenal, beta-apo-12'-
CC       carotenal, lutein, zeaxanthin, or lycopene, suggesting that the
CC       presence of one unsubstituted beta-ionone ring in a substrate with a
CC       molecular weight greater than C35 seems to be essential for enzyme
CC       activity. {ECO:0000269|PubMed:19366683}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=all-trans-beta-carotene + O2 = 2 all-trans-retinal;
CC         Xref=Rhea:RHEA:32887, ChEBI:CHEBI:15379, ChEBI:CHEBI:17579,
CC         ChEBI:CHEBI:17898; EC=1.13.11.63; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_02093, ECO:0000269|PubMed:19366683};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02093,
CC         ECO:0000269|PubMed:19366683};
CC       Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000269|PubMed:19366683};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=37 uM for beta-carotene {ECO:0000269|PubMed:19366683};
CC         KM=29 uM for beta-cryptoxanthin {ECO:0000269|PubMed:19366683};
CC         KM=147 uM for beta-apo-4'-carotenal {ECO:0000269|PubMed:19366683};
CC         KM=169 uM for alpha-carotene {ECO:0000269|PubMed:19366683};
CC         KM=382 uM for gamma-carotene {ECO:0000269|PubMed:19366683};
CC         Note=The kcat is 4.5-fold higher with beta-carotene than with beta-
CC         cryptoxanthin as substrate.;
CC       pH dependence:
CC         Optimum pH is 8.0. {ECO:0000269|PubMed:19366683};
CC       Temperature dependence:
CC         Optimum temperature is 40 degrees Celsius. Above this temperature,
CC         the enzyme activity decreases significantly, exhibiting 66% of the
CC         maximum activity at 50 degrees Celsius. Below 40 degrees Celsius, the
CC         enzyme activity decreases with decreasing temperature, exhibiting 15%
CC         of the maximum activity at 25 degrees Celsius. The half-lives of the
CC         enzyme at 35, 40, 45, 50, and 55 degrees Celsius are 17.6, 15.0,
CC         12.5, 6.1, and 1.5 hours, respectively.
CC         {ECO:0000269|PubMed:19366683};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19366683}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|HAMAP-Rule:MF_02093,
CC       ECO:0000305}; Multi-pass membrane protein {ECO:0000255|HAMAP-
CC       Rule:MF_02093, ECO:0000305}.
CC   -!- BIOTECHNOLOGY: Could be used for high retinal production.
CC       {ECO:0000269|PubMed:20229064}.
CC   -!- SIMILARITY: Belongs to the Brp/Blh beta-carotene diooxygenase family.
CC       {ECO:0000255|HAMAP-Rule:MF_02093, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ065755; AAY68319.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q4PNI0; -.
DR   KEGG; ag:AAY68319; -.
DR   BioCyc; MetaCyc:MON-17377; -.
DR   BRENDA; 1.13.11.63; 3186.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0003834; F:beta-carotene 15,15'-dioxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0010436; F:carotenoid dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016121; P:carotene catabolic process; IDA:UniProtKB.
DR   GO; GO:0042574; P:retinal metabolic process; IDA:UniProtKB.
DR   HAMAP; MF_02093; Beta_carotene_diox; 1.
DR   InterPro; IPR022270; Blh_monoox.
DR   Pfam; PF15461; BCD; 1.
DR   TIGRFAMs; TIGR03753; blh_monoox; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Dioxygenase; Iron; Membrane; Metal-binding; Oxidoreductase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..275
FT                   /note="Beta-carotene 15,15'-dioxygenase"
FT                   /id="PRO_0000408499"
FT   TRANSMEM        1..21
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        36..56
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        57..77
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        91..111
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        127..147
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        160..180
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        210..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   TRANSMEM        244..264
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093"
FT   BINDING         21
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093,
FT                   ECO:0000305|PubMed:19366683"
FT   BINDING         78
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093,
FT                   ECO:0000305|PubMed:19366683"
FT   BINDING         188
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093,
FT                   ECO:0000305|PubMed:19366683"
FT   BINDING         192
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02093,
FT                   ECO:0000305|PubMed:19366683"
FT   MUTAGEN         21
FT                   /note="H->A: 3% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:19366683"
FT   MUTAGEN         78
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:19366683"
FT   MUTAGEN         188
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:19366683"
FT   MUTAGEN         192
FT                   /note="H->A: 5% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:19366683"
SQ   SEQUENCE   275 AA;  31037 MW;  D571B00FCA434036 CRC64;
     MGLMLIDWCA LALVVFIGLP HGALDAAISF SMISSAKRIA RLAGILLIYL LLATAFFLIW
     YQLPAFSLLI FLLISIIHFG MADFNASPSK LKWPHIIAHG GVVTVWLPLI QKNEVTKLFS
     ILTNGPTPIL WDILLIFFLC WSIGVCLHTY ETLRSKHYNI AFELIGLIFL AWYAPPLVTF
     ATYFCFIHSR RHFSFVWKQL QHMSSKKMMI GSAIILSCTS WLIGGGIYFF LNSKMIASEA
     ALQTVFIGLA ALTVPHMILI DFIFRPHSSR IKIKN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024